PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy
Y Gao, C Wu, X Chen, L Ma, X Zhang, J Chen… - Frontiers in …, 2022 - frontiersin.org
Cancer immunotherapy, especially immune-checkpoint inhibitors (ICIs), has paved a new
way for the treatment of many types of malignancies, particularly advanced-stage cancers …
way for the treatment of many types of malignancies, particularly advanced-stage cancers …
Body Composition and Radiomics From 18F-FDG PET/CT Together Help Predict Prognosis for Patients With Stage IV Non–Small Cell Lung Cancer
Y Zhang, W Tan, Z Zheng, J Wang… - Journal of computer …, 2023 - journals.lww.com
Purpose To determine whether integration of data on body composition and radiomic
features obtained using baseline 18 F-FDG positron emission tomography/computed …
features obtained using baseline 18 F-FDG positron emission tomography/computed …
The correlation between PD-L1 expression and metabolic parameters of 18FDG PET/CT and the prognostic value of PD-L1 in non-small cell lung cancer
X Xu, J Li, Y Yang, S Sang, S Deng - Clinical Imaging, 2022 - Elsevier
Objectives In the present study, we aimed to investigate the relationship between metabolic
parameters of 18 F-fluorodeoxyglucose positron emission computed tomography (18 F-FDG …
parameters of 18 F-fluorodeoxyglucose positron emission computed tomography (18 F-FDG …
The predictive value of total-body PET/CT in non-small cell lung cancer for the PD-L1 high expression
B Hu, H Jin, X Li, X Wu, J Xu, Y Gao - Frontiers in Oncology, 2022 - frontiersin.org
Purpose Total-body positron emission tomography/computed tomography (PET/CT)
provides faster scanning speed, higher image quality, and lower injected dose. To …
provides faster scanning speed, higher image quality, and lower injected dose. To …